The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity

Jeffrey A. Rubens, Sabrina Z. Wang, Antoinette Price, Melanie F. Weingart, Sariah J. Allen, Brent A. Orr, Charles G. Eberhart, Eric H. Raabe

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences